Filings For: BlossomHill Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
BlossomHill Therapeutics, Inc. (BLSM) 9/18/2026 7:45:44 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026
BlossomHill Therapeutics, Inc. (BLSM) 9/18/2026 7:15:49 AM   View Earnings SEC 2Q 2026 Assets $124,131,000 EPS -$8.75